Compare GRFS & EAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GRFS | EAT |
|---|---|---|
| Founded | 1940 | 1975 |
| Country | Spain | United States |
| Employees | 25247 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8B | 6.3B |
| IPO Year | N/A | 1994 |
| Metric | GRFS | EAT |
|---|---|---|
| Price | $8.04 | $143.34 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 19 |
| Target Price | $10.15 | ★ $184.59 |
| AVG Volume (30 Days) | 699.4K | ★ 1.1M |
| Earning Date | 01-01-0001 | 04-27-2026 |
| Dividend Yield | ★ 1.77% | N/A |
| EPS Growth | N/A | ★ 144.71 |
| EPS | N/A | ★ 5.03 |
| Revenue | N/A | ★ $5,384,200,000.00 |
| Revenue This Year | $5.33 | $8.99 |
| Revenue Next Year | $6.50 | $5.47 |
| P/E Ratio | ★ $18.67 | $28.58 |
| Revenue Growth | N/A | ★ 21.95 |
| 52 Week Low | $6.19 | $100.30 |
| 52 Week High | $11.14 | $187.12 |
| Indicator | GRFS | EAT |
|---|---|---|
| Relative Strength Index (RSI) | 34.22 | 46.41 |
| Support Level | $7.64 | $141.15 |
| Resistance Level | $9.11 | $154.19 |
| Average True Range (ATR) | 0.28 | 5.55 |
| MACD | -0.09 | 0.61 |
| Stochastic Oscillator | 17.96 | 58.65 |
Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.
Brinker International Inc operates casual dining restaurants under the brand's Chili Grill and Bar (Chili's) and Maggiano's Little Italy (Maggiano's). Chili's falls in the Bar and Grill category of casual dining. Its menu features Fresh Mex and Fresh Tex favorites including signature items such as slow-smoked baby back ribs, craft burgers, fajitas, and bottomless chips and salsa paired with tableside guacamole. Maggiano's is an Italian restaurant brand with a full lunch and dinner menu offering chef-prepared, such as appetizers, chicken, seafood, veal and prime steaks, and desserts. The company generates maximum revenue from Chili's segment.